Molecule Information
General Information of the Molecule (ID: Mol00838)
| Name |
Beta-lactamase (BLA)
,Escherichia coli
|
||||
|---|---|---|---|---|---|
| Synonyms |
Penicillinase; oxa2
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
bla
|
||||
| Gene ID | |||||
| Sequence |
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR Click to Show/Hide
|
||||
| Function |
This is an oxacillin-hydrolyzing beta-lactamase.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Gram-negative bacterial infection | [1], [2] | |||
| Resistant Disease | Gram-negative bacterial infection [ICD-11: 1B74-1G40] | |||
| Resistant Drug | Amoxicillin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Escherichia coli | 668369 | ||
| Acinetobacter johnsonii LIM75 | 40214 | |||
| Aeromonas allosaccharophila LIM82 | 656 | |||
| Citrobacter freundii LIM86 | 546 | |||
| Escherichia coli MFDpir | 562 | |||
| Experiment for Molecule Alteration |
Whole genome sequence assay | |||
| Experiment for Drug Resistance |
Agar dilution method assay; broth microdilution method assay | |||
| Mechanism Description | All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib]. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Gram-negative bacterial infection | [1], [2] | |||
| Resistant Disease | Gram-negative bacterial infection [ICD-11: 1B74-1G40] | |||
| Resistant Drug | Ceftazidime | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Escherichia coli | 668369 | ||
| Acinetobacter johnsonii LIM75 | 40214 | |||
| Aeromonas allosaccharophila LIM82 | 656 | |||
| Citrobacter freundii LIM86 | 546 | |||
| Escherichia coli MFDpir | 562 | |||
| Experiment for Molecule Alteration |
Whole genome sequence assay | |||
| Experiment for Drug Resistance |
Agar dilution method assay; broth microdilution method assay | |||
| Mechanism Description | All known class 3 integrons harbour gene cassettes encoding resistance to Beta-lactams (blaIMP, blaGES, blaBEL, blaOXA-256) and aminoglycosides [aac(6')-Ib]. | |||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
